688221 fundamentals
An in-depth look to FRONTIER BIOTECHNOLOGIES INC. operating, investing, and financing activities
688221 free cash flow for Q1 24 is -50.3 M CNY. For 2023, 688221 free cash flow was -378.71 M CNY and operating cash flow was -249.36 M CNY.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM